This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Stocks Poised to Break Out

Amarin

If you're looking for a biotech player that looks poised to breakout, then put Amarin (AMRN) on your trading radar. This company is a clinical-stage biopharmaceutical player focused on developing improved treatments for cardiovascular disease. Amarin's development programs capitalize in the field of lipid science and the therapeutic benefits of essential fatty acids in cardiovascular disease. This stock is off to a fantastic start so far in 2011, with shares up over 76%.

If you take a look at the chart for Amarin, you'll see that this stock has been trading inside of a channel chart pattern for the past two months. During that time, the stock has been trading between the upper-end at around $15 a share and the lower-end at around $13.30 a share. Traders should now watch for a breakout above the upper-end if they're bullish on AMRN.

A move above $15.02 a share and then above its 50-day moving average of $15.74 a share could trigger a big bullish run for AMRN. I would suggest watching for a breakout that comes on big volume above these levels. Look for volume that's close to or well above its three-month average action of 2.9 million shares. This stock has a ton of upside if the breakout does hit because this name was just trading at $19.87 back in early June.

One could simply be a buyer of this stock right now and anticipate the breakout above $15.02 a share. I would add to any long position aggressively if you see AMRN trade above $15.74 on big volume. The only way I would get short this stock is if you see it trade below $13.30 on heavy volume, since that level has already triggered a double bottom support zone.

5 of 6

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,055.87 -116.81 -0.68%
S&P 500 1,982.77 -11.52 -0.58%
NASDAQ 4,508.6880 -19.0010 -0.42%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs